Department of Radiation Oncology, University of Texas Health and Science Center, San Antonio, TX 78229, USA.
Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
Trends Pharmacol Sci. 2024 Nov;45(11):955-957. doi: 10.1016/j.tips.2024.09.008. Epub 2024 Oct 9.
Breast Cancer Type 1 Susceptibility Protein (BRCA)-1 existing in several functionally distinct complexes, promotes DNA repair of DNA double-strand breaks (DSBs). A recent study by Tang and colleagues identifies the lysine methyltransferase Disruptor of Telomeric Silencing 1-Like (DOT1L) involved in modifying Receptor-Associated Protein 80 (RAP80) to promote BRCA1-A complex localization and repair functions at DNA breaks. This study illuminates a potential therapeutic target for cancer radiotherapy.
乳腺癌易感蛋白 1(BRCA)-1 存在于几个功能不同的复合物中,可促进 DNA 双链断裂(DSBs)的修复。最近,Tang 及其同事的一项研究确定了赖氨酸甲基转移酶端粒沉默干扰因子 1 样(DOT1L),该酶参与修饰受体相关蛋白 80(RAP80),以促进 BRCA1-A 复合物在 DNA 断裂处的定位和修复功能。这项研究为癌症放射治疗提供了一个潜在的治疗靶点。